881 related articles for article (PubMed ID: 19684442)
1. Epidemiology of mucosal human papillomavirus infection and associated diseases.
Trottier H; Burchell AN
Public Health Genomics; 2009; 12(5-6):291-307. PubMed ID: 19684442
[TBL] [Abstract][Full Text] [Related]
2. The epidemiology of genital human papillomavirus infection.
Trottier H; Franco EL
Vaccine; 2006 Mar; 24 Suppl 1():S1-15. PubMed ID: 16406226
[TBL] [Abstract][Full Text] [Related]
3. Strategies against human papillomavirus infection and cervical cancer.
Jung WW; Chun T; Sul D; Hwang KW; Kang HS; Lee DJ; Han IK
J Microbiol; 2004 Dec; 42(4):255-66. PubMed ID: 15650698
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus: often harmless but in some cases carcinogenic.
Prescrire Int; 2007 Jun; 16(89):115-9. PubMed ID: 17585425
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus infections of the genital and respiratory tracts in young children.
Sinal SH; Woods CR
Semin Pediatr Infect Dis; 2005 Oct; 16(4):306-16. PubMed ID: 16210110
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology and natural history of genital human papillomavirus infection.
Weaver BA
J Am Osteopath Assoc; 2006 Mar; 106(3 Suppl 1):S2-8. PubMed ID: 16729554
[TBL] [Abstract][Full Text] [Related]
7. [Human papillomavirus prophylactic vaccines: stakes and perspectives].
Hantz S; Alain S; Denis F
Gynecol Obstet Fertil; 2006; 34(7-8):647-55. PubMed ID: 16807045
[TBL] [Abstract][Full Text] [Related]
8. Annual disease burden due to human papillomavirus (HPV) 6 and 11 infections in Finland.
Syrjänen KJ
Scand J Infect Dis Suppl; 2009; 107():3-32. PubMed ID: 19408160
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus and cervical cancer: burden of illness and basis for prevention.
Trottier H; Franco EL
Am J Manag Care; 2006 Dec; 12(17 Suppl):S462-72. PubMed ID: 17203990
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology, clinical manifestations, and recent advances in vaccination against human papillomavirus.
Broomall EM; Reynolds SM; Jacobson RM
Postgrad Med; 2010 Mar; 122(2):121-9. PubMed ID: 20203463
[TBL] [Abstract][Full Text] [Related]
11. Genital human papillomavirus infection.
Dunne EF; Markowitz LE
Clin Infect Dis; 2006 Sep; 43(5):624-9. PubMed ID: 16886157
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus infection and the development of cervical cancer and related genital neoplasias.
Paavonen J
Int J Infect Dis; 2007 Nov; 11 Suppl 2():S3-9. PubMed ID: 18162244
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus: the burden of infection.
Wiley D; Masongsong E
Obstet Gynecol Surv; 2006 Jun; 61(6 Suppl 1):S3-14. PubMed ID: 16729902
[TBL] [Abstract][Full Text] [Related]
14. [Morphologic manifestations of human papillomavirus infection in the vulvar and anogenital region].
Hadzić B; Djurdjević S; Hadzić M; Jerant-Patić V
Med Pregl; 1998; 51(5-6):265-70. PubMed ID: 9720356
[TBL] [Abstract][Full Text] [Related]
15. A review of prophylactic human papillomavirus vaccines: recommendations and monitoring in the US.
Dunne EF; Datta SD; E Markowitz L
Cancer; 2008 Nov; 113(10 Suppl):2995-3003. PubMed ID: 18980283
[TBL] [Abstract][Full Text] [Related]
16. Epidermodysplasia verruciformis-associated and genital-mucosal high-risk human papillomavirus DNA are prevalent in nevus sebaceus of Jadassohn.
Carlson JA; Cribier B; Nuovo G; Rohwedder A
J Am Acad Dermatol; 2008 Aug; 59(2):279-94. PubMed ID: 18638629
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology and natural history of HPV.
Cox JT
J Fam Pract; 2006 Nov; Suppl():3-9. PubMed ID: 17366752
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus infection: epidemiology and pathophysiology.
Steben M; Duarte-Franco E
Gynecol Oncol; 2007 Nov; 107(2 Suppl 1):S2-5. PubMed ID: 17938014
[TBL] [Abstract][Full Text] [Related]
19. Annual disease burden due to human papillomavirus 16 and 18 infections in Finland.
Syrjänen KJ
Scand J Infect Dis Suppl; 2009; 108():2-32. PubMed ID: 19939209
[TBL] [Abstract][Full Text] [Related]
20. The prevalence of human papillomavirus genotypes in nonmelanoma skin cancers of nonimmunosuppressed individuals identifies high-risk genital types as possible risk factors.
Iftner A; Klug SJ; Garbe C; Blum A; Stancu A; Wilczynski SP; Iftner T
Cancer Res; 2003 Nov; 63(21):7515-9. PubMed ID: 14612553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
